Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

June 2013 - FRMC

Department
06/26/2013
The FDA approved Humalog® (insulin lispro) in June 1996 to improve glycemic control in adults and children with diabetes. The drug, a rapid acting human insulin analog, is marketed by Eli Lilly and Company. Insulin lispro comes in various...
The FDA approved Humalog® (insulin lispro) in June 1996 to improve glycemic control in adults and children with diabetes. The drug, a rapid acting human insulin analog, is marketed by Eli Lilly and Company. Insulin lispro comes in various...
The FDA approved Humalog®...
06/26/2013
First Report Managed Care
06/26/2013

Tim Casey

Tim Casey
Orlando—Although the prevalence of prostate cancer is stable, it remains the most common cancer for men. The introduction of new therapies has led to improved survival rates, but most men must take several agents to treat the disease,...
Orlando—Although the prevalence of prostate cancer is stable, it remains the most common cancer for men. The introduction of new therapies has led to improved survival rates, but most men must take several agents to treat the disease,...
Orlando—Although the prevalence...
06/26/2013
First Report Managed Care
06/26/2013

Tim Casey

Tim Casey
Orlando—Since 2000, the number of treatments for myeloma has expanded with the introduction of proteasome inhibitors and other immunomodulatory agents. Still, the disease is complex, and there are multiple options available for the treatment...
Orlando—Since 2000, the number of treatments for myeloma has expanded with the introduction of proteasome inhibitors and other immunomodulatory agents. Still, the disease is complex, and there are multiple options available for the treatment...
Orlando—Since 2000, the number...
06/26/2013
First Report Managed Care

Department

News Connection
06/26/2013
The FDA expanded the approval of Simponi®(golimumab) in May 2013 to treat adults with moderately to severely active ulcerative colitis. The drug, an injectable anti-tumor necrosis factor-alpha treatment from Janssen Biotech, Inc, is also...
The FDA expanded the approval of Simponi®(golimumab) in May 2013 to treat adults with moderately to severely active ulcerative colitis. The drug, an injectable anti-tumor necrosis factor-alpha treatment from Janssen Biotech, Inc, is also...
The FDA expanded the approval of...
06/26/2013
First Report Managed Care
Conference Insider
06/26/2013

Tim Casey

Tim Casey
New Orleans—An analysis of a claims database in the United States, which covers >25 million lives annually, found that the incidence of pathologic myopia (PM) was 2.75 per 10,000 individuals in 2011, while the prevalence of PM was 9.64 per...
New Orleans—An analysis of a claims database in the United States, which covers >25 million lives annually, found that the incidence of pathologic myopia (PM) was 2.75 per 10,000 individuals in 2011, while the prevalence of PM was 9.64 per...
New Orleans—An analysis of a...
06/26/2013
First Report Managed Care
Conference Insider
06/26/2013

Tim Casey

Tim Casey
Patients who took the extended release combination of phentermine and topiramate and modified their lifestyle to manage obesity developed fewer comorbidities than they would have without treatment, according to an economic model. 
Patients who took the extended release combination of phentermine and topiramate and modified their lifestyle to manage obesity developed fewer comorbidities than they would have without treatment, according to an economic model. 
Patients who took the extended...
06/26/2013
First Report Managed Care
Conference Insider
06/26/2013

Tim Casey

Tim Casey
Arlington, Virginia—Of all of the budget issues facing states, among the most pressing is how to pay for healthcare services. States are particularly concerned with providing adequate services and lowering costs of delivering care for dual...
Arlington, Virginia—Of all of the budget issues facing states, among the most pressing is how to pay for healthcare services. States are particularly concerned with providing adequate services and lowering costs of delivering care for dual...
Arlington, Virginia—Of all of...
06/26/2013
First Report Managed Care
Conference Insider
06/26/2013

Tim Casey

Tim Casey
In order to form advantageous Medicaid accountable care organizations (ACOs), proper methods to combat uncoordinated care must first be established.
In order to form advantageous Medicaid accountable care organizations (ACOs), proper methods to combat uncoordinated care must first be established.
In order to form advantageous...
06/26/2013
First Report Managed Care
Conference Insider
06/26/2013

Tim Casey

Tim Casey
Orlando—The Centers for Medicare & Medicaid Services (CMS) introduced its 5 Star Ratings system to hold Medicare Advantage plans responsible for delivering improved care and for providing information to patients to make better decisions....
Orlando—The Centers for Medicare & Medicaid Services (CMS) introduced its 5 Star Ratings system to hold Medicare Advantage plans responsible for delivering improved care and for providing information to patients to make better decisions....
Orlando—The Centers for Medicare...
06/26/2013
First Report Managed Care
Conference Insider
06/26/2013

Tim Casey

Tim Casey
Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...
Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...
Orlando—As a partner in Oliver...
06/26/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement